Annual CFO
-$1.09 M
NaN%
December 31, 2022
Summary
- As of February 10, 2025, PBAX annual cash flow from operations is -$1.09 million
Performance
PBAX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$256.10 K
+$627.00 K+71.00%
September 30, 2023
Summary
- As of February 10, 2025, PBAX quarterly cash flow from operations is -$256.10 thousand, with the most recent change of +$627.00 thousand (+71.00%) on September 30, 2023.
- Over the past year, PBAX quarterly CFO has dropped by -$81.80 thousand (-46.93%).
Performance
PBAX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$1.71 M
-$81.80 K-5.02%
September 30, 2023
Summary
- As of February 10, 2025, PBAX TTM cash flow from operations is -$1.71 million, with the most recent change of -$81.80 thousand (-5.02%) on September 30, 2023.
- Over the past year, PBAX TTM CFO has dropped by -$991.00 thousand (-137.81%).
Performance
PBAX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
PBAX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -46.9% | -137.8% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
PBAX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +46.9% | +244.8% | +455.0% | at low |
| 5 y | 5-year | at high | at low | +46.9% | +244.8% | +455.0% | at low |
| alltime | all time | at high | at low | +46.9% | +244.8% | +455.0% | at low |
Phoenix Biotech Acquisition Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$256.10 K(-71.0%) | -$1.71 M(+5.0%) |
| Jun 2023 | - | -$883.10 K(+346.5%) | -$1.63 M(+65.8%) |
| Mar 2023 | - | -$197.80 K(-47.0%) | -$981.90 K(-10.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$1.09 M | -$373.10 K(+114.1%) | -$1.09 M(+51.9%) |
| Sep 2022 | - | -$174.30 K(-26.4%) | -$719.10 K(+32.0%) |
| Jun 2022 | - | -$236.70 K(-23.2%) | -$544.80 K(+76.8%) |
| Mar 2022 | - | -$308.10 K | -$308.10 K |
FAQ
- What is Phoenix Biotech Acquisition annual cash flow from operations?
- What is the all time high annual CFO for Phoenix Biotech Acquisition?
- What is Phoenix Biotech Acquisition quarterly cash flow from operations?
- What is the all time high quarterly CFO for Phoenix Biotech Acquisition?
- What is Phoenix Biotech Acquisition quarterly CFO year-on-year change?
- What is Phoenix Biotech Acquisition TTM cash flow from operations?
- What is the all time high TTM CFO for Phoenix Biotech Acquisition?
- What is Phoenix Biotech Acquisition TTM CFO year-on-year change?
What is Phoenix Biotech Acquisition annual cash flow from operations?
The current annual CFO of PBAX is -$1.09 M
What is the all time high annual CFO for Phoenix Biotech Acquisition?
Phoenix Biotech Acquisition all-time high annual cash flow from operations is -$1.09 M
What is Phoenix Biotech Acquisition quarterly cash flow from operations?
The current quarterly CFO of PBAX is -$256.10 K
What is the all time high quarterly CFO for Phoenix Biotech Acquisition?
Phoenix Biotech Acquisition all-time high quarterly cash flow from operations is -$174.30 K
What is Phoenix Biotech Acquisition quarterly CFO year-on-year change?
Over the past year, PBAX quarterly cash flow from operations has changed by -$81.80 K (-46.93%)
What is Phoenix Biotech Acquisition TTM cash flow from operations?
The current TTM CFO of PBAX is -$1.71 M
What is the all time high TTM CFO for Phoenix Biotech Acquisition?
Phoenix Biotech Acquisition all-time high TTM cash flow from operations is -$308.10 K
What is Phoenix Biotech Acquisition TTM CFO year-on-year change?
Over the past year, PBAX TTM cash flow from operations has changed by -$991.00 K (-137.81%)